Product Information

DEXLANSOPRAZOLE DR 60 MG CAP is a generic product labeled by Endo USA Inc., priced at $3.6568 per EA under NDC 49884014811. Its NADAC has been published 189 times since Jan 11, 2023.

FDA first approved this application on Apr 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEXLANSOPRAZOLE DR 60 MG CAP

Dexlansoprazole
$3.6568per EA

Strength

60 mg/1

Manufacturer

Endo USA Inc.

NDC

49884014811

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DEXLANSOPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA202294

FDA Approved

4/19/2017

TE Code

AB

On Market Since

11/22/2022

Pharmacological Classes

Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has been published 189 times since Jan 11, 2023, and over the history we have for it it has declined 49.3%. The table below summarizes its recorded NADAC range and movement.

Current price$3.6568 per EA
All-time high$7.3215 (Jul 12, 2023)
All-time low$3.6568 (Aug 19, 2026)
52-week high$4.6782
52-week low$3.6568
Median price$4.8972
Average price$5.4520
Largest weekly change-16.5% (Nov 20, 2024)
Weeks tracked189
Tracking sinceJan 11, 2023

Price History

1W

-0.7%

1M

-0.7%

3M

-7.2%

6M

-14.1%

1Y

-21.8%

3Y

-48.3%

5Y

N/A

All

-49.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXLANSOPRAZOLE DR 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXLANSOPRAZOLE DR 60 MG CAP, manufactured by Endo USA Inc., is $3.6568 per EA (NDC 49884014811), effective Aug 19, 2026.

How has the price of DEXLANSOPRAZOLE DR 60 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has declined 49.3%. It has been tracked across 189 weekly CMS publications since Jan 11, 2023.

What are the highest and lowest recorded NADAC prices for DEXLANSOPRAZOLE DR 60 MG CAP?

Since Jan 11, 2023, the NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has ranged from a low of $3.6568 (Aug 19, 2026) to a high of $7.3215 (Jul 12, 2023), with a median of $4.8972 per EA.

Are there cheaper alternatives to DEXLANSOPRAZOLE DR 60 MG CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXLANSOPRAZOLE DR 60 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXLANSOPRAZOLE DR 60 MG CAP?

DEXLANSOPRAZOLE DR 60 MG CAP (NDC 49884014811) is labeled by Endo USA Inc., and CMS classifies it as a generic product.